LEISHMANIASIS
Diagnosis, Diagnostics, Immunodiagnosis &
Immunodiagnostics:
8016.
Gangneux JP, Menotti J, Lorenzo F, Sarfati C, Blanche H, Bui H, Pratlong
F, Garin YJ, Derouin F. Prospective value of PCR amplification and sequencing
for diagnosis and typing of old world Leishmania infections in an area of
nonendemicity. J Clin Microbiol. 2003 Apr;41(4):1419-22.
8017.
Goswami BK, Datta S, Chakrabarti S, Chakrabarti S, Giri A, Debnath NB,
Datta K, Bandopadhayay G, Das S. Experience of visceral leishmaniasis in the
northern districts of West Bengal – the emerging sodium stibogluconate
unrespensiveness. Indian med J 2002, 96 (7), 173-6.
8018.
Haseeb AN, el-Shazly AM, Arafa MA, Morsy AT. Evaluation of
excretory/secretory Fasciola (Fhes) antigen in diagnosis of human fascioliasis.
J Egypt Soc Parasitol. 2003 Apr;33(1):123-38.
8019.
Ikonomopoulos J, Kokotas S, Gazouli M, Zavras A, Stoitsiou M, Gorgoulis
VG. Molecular diagnosis of
leishmaniosis in dogs. Comparative application of traditional diagnostic methods
and the proposed assay on clinical samples. Vet Parasitol. 2003 Apr
18;113(2):99-113.
8020.
Rahman SB, Bari AU. Laboratory profile in patients of cutaneous
leishmaniasis from various regions of Pakistan. J Coll Physicians Surg Pak. 2003
Jun;13(6):313-6.
8021.
Reithinger R, Espinoza JC, Courtenay O, Davies CR. Evaluation of PCR as a
diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic
dogs (Canis familiaris). J Clin Microbiol. 2003 Apr;41(4):1486-93.
8022.
Whittemore JC, Salman MD. Think screening unnecessary, unrealistic for
all blood donors. J Am Vet Med Assoc. 2003 Jun 1;222(11):1502; author reply
1502.
Pathogenesis:
8023.
Bertholet S, Dickensheets HL, Sheikh F, Gam AA, Donnelly RP, Kenney RT.
Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in
human macrophages: a novel mechanism for intracellular parasite suppression of
activation. Infect Immun. 2003 Apr;71(4):2095-101.
8024. Cordeiro-da-Silva A, Cardoso L, Araujo N, Castro H, Tomas A, Rodrigues M, Cabral M, Vergnes B, Sereno D, Ouaissi A. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications. Immunol Lett. 2003 Apr 3;86(2):155-62.
8025.
Lang T, Courret N, Colle JH, Milon G, Antoine JC. The levels and patterns
of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with
Leishmania major by inoculation into the ear dermis depend on the infectiousness
and size of the inoculum. Infect Immun. 2003 May;71(5):2674-83.
8026.
Lima VM, Goncalves ME, Ikeda FA, Luvizotto MC, Feitosa MM. Anti-leishmania
antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis. Braz J
Med Biol Res. 2003 Apr;36(4):485-9. Epub 2003 Apr 08.
8027.
Pelletier I, Hashidate T, Urashima T, Nishi N, Nakamura T, Futai M, Arata
Y, Kasai K-, Hirashima M, Hirabayashi J, Sato S. Specific recognition of
Leishmania major poly-beta-galactosyl epitopes by galectin-9: possible
implication of galectin-9 in interaction between L. major and host cells. J Biol
Chem. 2003 Jun 20;278(25):22223-30. Epub 2003 Apr 08.
8028.
Reithinger R, Espinoza JC, Courtenay O, Davies CR. Evaluation of PCR as a
diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic
dogs (Canis familiaris). J Clin Microbiol. 2003 Apr;41(4):1486-93.
Therapy:
8029.
Carter KC, Sundar S, Spickett C, Pereira OC, Mullen AB. The in vivo
susceptibility of Leishmania donovani to sodium stibogluconate is drug specific
and can be reversed by inhibiting glutathione biosynthesis. Antimicrob Agents
Chemother. 2003 May;47(5):1529-35.
8030.
Cauchetier E, Paul M, Rivollet D, Fessi H, Astier A, Deniau M.
Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the
treatment of murine visceral leishmaniasis. Ann Trop Med Parasitol. 2003
Apr;97(3):259-68.
8031.
Montero JA, Ruiz-Moreno JM, Sanchis E. Intraretinal hemorrhage associated
with leishmaniasis. Ophthalmic Surg Lasers Imaging. 2003 May-Jun;34(3):212-4.
Back |